Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.21.22 extracted from

  • Kitazawa, T.; Shima, M.
    Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity (2018), Int. J. Hematol., 111, 20-30 .
    View publication on PubMed

Activating Compound

Activating Compound Comment Organism Structure
emicizumab factorIXa/factorX bispecific antibody. Emicizumab functions as a cofactor to promote the factor IXa-catalyzed factor X activation Homo sapiens
Factor VIIIa factor VIIIa may directly modulate the active catalytic site of factor IXa to increase kcat of the factor IXa-catalyzed factor X activation Homo sapiens

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
Factor X + H2O Homo sapiens
-
Factor Xa + ?
-
?

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
Factor X + H2O
-
Homo sapiens Factor Xa + ?
-
?

Synonyms

Synonyms Comment Organism
FIXa
-
Homo sapiens

Turnover Number [1/s]

Turnover Number Minimum [1/s] Turnover Number Maximum [1/s] Substrate Comment Organism Structure
0.048
-
Factor X in the presence of emicizumab, pH and temperature not specified in the publication Homo sapiens
2.1
-
Factor X in the presence of factor VIIIa, pH and temperature not specified in the publication Homo sapiens